vitaepharma.com/
Top-News
Vitae Pharma
Beiträge: 12
Zugriffe: 5.105 / Heute: 3
Zugriffe: 5.105 / Heute: 3
|
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF - Acc
Perf. 12M: +67,93%
Amundi ETF Leveraged MSCI USA Daily UCITS ETF - EUR (C/D)
Perf. 12M: +51,78%
Amundi MSCI India II UCITS ETF - EUR Acc
Perf. 12M: +38,37%
Amundi Japan TOPIX II UCITS ETF - EUR Hedeged Dist
Perf. 12M: +36,98%
www.finanzen.net/analyse/...y-Stifel_Nicolaus__Co__Inc__520054
seekingalpha.com/news/...tae-pharma-added-to-small-cap-indexes
eigentlich ein interessanter Wert,
vitaepharma.com/pipeline/
Aber mal abwarten, wo die landet....
vitaepharma.com/pipeline/
Aber mal abwarten, wo die landet....
globenewswire.com/news-release/2015/02/27/...fvtc=2&fvtv=1
Absturz:
www.streetinsider.com/Corporate+News/...aluation/10318738.html
Absturz:
www.streetinsider.com/Corporate+News/...aluation/10318738.html
<< Back
Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study of First-in-Class RORyt Inhibitor VTP-43742 in Autoimmune Disorders
Single ascending doses of VTP-43742 safe and generally well-tolerated, demonstrated once-daily pharmacokinetics
Robust ex vivo biomarker response, suppressing pro-inflammatory IL-17A by more than 90 percent
Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study of First-in-Class RORyt Inhibitor VTP-43742 in Autoimmune Disorders
Single ascending doses of VTP-43742 safe and generally well-tolerated, demonstrated once-daily pharmacokinetics
Robust ex vivo biomarker response, suppressing pro-inflammatory IL-17A by more than 90 percent
Boerse ist reine Psychologie. Nicht mehr und nicht weniger.
www.finanzen.net/analyse/...y-Stifel_Nicolaus__Co__Inc__520054
www.finanzen.net/analyse/...perform-BMO_Capital_Markets_574283
Neueste Beiträge aus dem Vitae Pharmaceuticals Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 11 | Vitae Pharma | Balu4u | Balu4u | 25.04.21 03:41 |
